Concepedia

Michael A. Mohutsky

MA

Statistics

Publications

22

Citations

799

H-Index

19

Active since

2001

Affiliations

Eli Lilly (United States)(Current)

Vertex Pharmaceuticals (United States)

University of Washington

GlaxoSmithKline (United States)

Purdue University West Lafayette

Michael A. Mohutsky is an author at Eli Lilly (United States) specializing in pharmacology, pharmacokinetics, and pharmacy.

Publications per year

2001–2020

22

Publications

22

Possible Interaction between Warfarin and <i>Lycium Barbarum</i> L.

Annie Lam, Gary W. Elmer, Michael A. Mohutsky · Annals of Pharmacotherapy · 2001 · 93 citations

, , +16

Ginkgo biloba: Evaluation of CYP2C9 Drug Interactions In Vitro and In Vivo

Michael A. Mohutsky, Gail D. Anderson, John W. Miller et al. · American Journal of Therapeutics · 2006 · 72 citations

, , +13

Considerations from the Innovation and Quality Induction Working Group in Response to Drug-Drug Interaction Guidances from Regulatory Agencies: Focus on CYP3A4 mRNA In Vitro Response Thresholds, Variability, and Clinical Relevance

Jane R. Kenny, Diane Ramsden, David B. Buckley et al. · Drug Metabolism and Disposition · 2018 · 68 citations · Full text

, , +15

Prediction of CYP3A-Mediated Drug-Drug Interactions Using Human Hepatocytes Suspended in Human Plasma

Jialin Mao, Michael A. Mohutsky, John Harrelson et al. · Drug Metabolism and Disposition · 2011 · 56 citations · Full text

, , +17

Predictions of the In Vivo Clearance of Drugs from Rate of Loss Using Human Liver Microsomes for Phase I and Phase II Biotransformations

Michael A. Mohutsky, Jenny Y. Chien, Barbara J. Ring et al. · Pharmaceutical Research · 2006 · 55 citations

, , +16

1–5 of 22